Invesco India Small Cap Fund Direct Growth NAV at ₹54.6700 on 9 September; 3-Year CAGR at 22.76%

Key Takeaways 

• The NAV was nearly unchanged at ₹54.6700 on 9 September 2026, with a 0.02% decline. 
• The latest three-year CAGR stood at 22.76%, while recent data placed the five-year annualised return at 20.63%. 
• Fund-size readings were around ₹15,000 crore, with SIP and lump-sum entry points starting at ₹100 in the recent scheme data. 
• Net current assets and four leading equity holdings together represented 22.71% of the disclosed portfolio entries. 

Invesco India Small Cap Fund Direct Growth stood at ₹54.6700 on 9 September 2026. The NAV edged down by only 0.02% over the day. Its three-year CAGR was 22.76%, remaining close to the recent 22.79% reading from the preceding valuation snapshot. 

Recent longer-period data showed an 18.61% one-year return and a 20.63% five-year CAGR. The three-year annualised figure was therefore slightly above the five-year result, with the one-year number somewhat lower than both. Those differences reflect the market periods embedded in each trailing window. 

Assets under management were around ₹15,000 crore in the latest permitted records. The Direct Plan expense-ratio readings varied modestly by update timing, with recent figures between 0.40% and 0.63%. Both the SIP and lump-sum investment thresholds were listed at ₹100 in the latest scheme snapshot. The exit-load structure imposed 1% on qualifying units redeemed within 365 days beyond the stated load-free portion. 

Net current assets accounted for 5.14% of the disclosed portfolio. Sai Life Sciences represented 4.94%, Eternal 4.62%, Krishna Institute of Medical Sciences 4.10% and Aditya Infotech 3.91%. Those five entries represented 22.71%. The four named equity stocks alone accounted for 17.57%. 

The fund's beta stood at 1.10 and standard deviation at 5.65. Alpha was 16.79, with a Sharpe ratio of 0.94. Historical beta above one describes the relationship captured during the measurement period and does not set a fixed level of future sensitivity. 

The small-cap mandate remains central to interpreting both the return and risk readings, since the portfolio primarily operates outside India's large- and mid-cap company universe. 

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.